Investigations of leukocyte and inflammatory markers in pregnancies complicated by preeclampsia.


Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 15 05 2023
revised: 14 08 2023
accepted: 07 10 2023
medline: 5 12 2023
pubmed: 20 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Preeclampsia is a frequent and potentially fatal pregnancy complication. It can be challenging to make a timely diagnosis. Identifying clinically useful biochemical markers would be a remedying tool to support the diagnosis of preeclampsia. The aim was to investigate differential cell counts and acute phase reactants as diagnostic markers of preeclamptic third-trimester pregnancies and in relation to pregnancy term, gravidity and the severity of hypertension. Based on a cohort of 421 pregnant women, we included 174 participants (case n = 84, control n = 90) during the third trimester. Peripheral blood was sampled to measure differential white blood cell counts and acute phase reactants on the day of inclusion. The neutrophil-to-lymphocyte ratio and plasma haptoglobin levels were significantly increased in healthy pregnancies compared with preeclamptic pregnancies. Plasma ferritin levels and albumin levels were respectively increased and decreased in cases of preeclampsia compared with controls. Albumin was specific among multigravida. Plasma transferrin and high-sensitivity C-reactive protein (hs-CRP) levels were significantly decreased and increased, respectively, in cases with preterm preeclampsia compared with term preeclampsia. Plasma ferritin and albumin levels reflected higher inflammation in cases with preeclampsia compared with healthy pregnancies; the same did plasma transferrin and hs-CRP levels in preterm versus term preeclampsia. When considering the normal ranges plasma albumin and hs-CRP levels identified preeclamptic from healthy third-trimester pregnancies and preterm from term preeclampsia cases, respectively, with near-acceptable diagnostic performances. Further validation of the diagnostic value will require larger sample-sized studies with paired plasma and serum samples.

Identifiants

pubmed: 37857159
pii: S0165-0378(23)00369-8
doi: 10.1016/j.jri.2023.104163
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4
Biomarkers 0
Acute-Phase Proteins 0
Ferritins 9007-73-2
Transferrins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104163

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that the study was conducted without any commercial or associative interest that could represent a potential conflict of interest.

Auteurs

Hiba Iraqi Møller (HI)

Centre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Gry Persson (G)

Centre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.

Freja Bluhme Klok (FB)

Centre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.

Fie Juhl Vojdeman (FJ)

Department of Clinical Biochemistry, Holbaek Hospital, Denmark.

Morten Lebech (M)

Department of Obstetrics and Gynecology, The ReproHealth Research Consortium ZUH, Zealand University Hospital, Denmark.

Thomas Vauvert F Hviid (TVF)

Centre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: tvh@regionsjaelland.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH